Community-acquired pneumonia epidemiology and demographics

Revision as of 18:47, 7 February 2014 by Chetan Lokhande (talk | contribs)
Jump to navigation Jump to search

Pneumonia Main Page

Community-Acquired Pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Community-acquired pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Severity Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Ultrasound

Other Diagnostic Studies

Treatment

Hospital Admission Decision

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Community-acquired pneumonia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Community-acquired pneumonia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Community-acquired pneumonia epidemiology and demographics

CDC on Community-acquired pneumonia epidemiology and demographics

Community-acquired pneumonia epidemiology and demographics in the news

Blogs on Community-acquired pneumonia epidemiology and demographics

Directions to Hospitals Treating Community-acquired pneumonia

Risk calculators and risk factors for Community-acquired pneumonia epidemiology and demographics

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Epidemiology

  • Pneumonia is one of the leading cause of death in the world and sixth leading cause in the United States.
  • Mortality rate is low in patients treated in the outpatient department and somewhat higher in patients admitted.
  • A higher mortality rate is seen in invasive diseases, nursing home patients and severe bacteremia.
  • More than 40 % mortality rate is seen in ICU admitted patients.


References